Pharmacokinetics And Tolerability Of Subcutaneous Administration Of PF 04236921 In Healthy Volunteers

Phase I Pharmacokinetics And Tolerability Of PF-04236921 Following Subcutaneous Administration To Healthy Volunteers

This study will evaluate the safety, tolerability, and pharmacokinetics of PF-04236921 administered as a single subcutaneous dose in healthy volunteers.

Tolerability and Pharmacokinetics of subcutaneously administered dose of PF-04236921 in healthy volunteers

Inclusion Criteria:

• Healthy males between 18-55 years, inclusive.
• Healthy females of non-childbearing potential between 18 and 55 years, inclusive.

Exclusion Criteria:

• Evidence or history of clinically significant disease.
• Females of childbearing potential.